Details for New Drug Application (NDA): 040249
✉ Email this page to a colleague
The generic ingredient in ORPHENADRINE CITRATE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
Summary for 040249
Tradename: | ORPHENADRINE CITRATE |
Applicant: | Rising |
Ingredient: | orphenadrine citrate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 100MG | ||||
Approval Date: | Jan 29, 1999 | TE: | AB | RLD: | No |
Complete Access Available with Subscription